Good morning, everyone, and welcome to another working week. We hope the weekend respite was somehow relaxing and invigorating — despite the chaos — because that predictable routine of deadlines and Zoom and Skype meetings has returned. To cope, yes, we are relying on cups of stimulation. Our flavor today is glazed doughnut. Yum. Meanwhile, here are a few tidbits to get you going. We hope today is productive and calming. As always, stay in touch and stay safe — and please wear a mask. …

Infectious disease experts and doctors who have treated Covid-19 patients questioned whether President Trump’s illness might be more severe than his medical team and the White House have let on, pointing to at least three warning signs that came to light during a briefing from the president’s doctors on Sunday, STAT explains. The main concern is that Trump started receiving the steroid dexamethasone, which is recommended only for hospitalized Covid-19 patients who are on ventilators or require oxygen.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Someone explain to me. Don’t these companies have their data backed up? I mean, isn’t it an industry standard to back up data? Are there not companies that specialize in backing up data in case something happens? eResearch should have had a way to quickly reboot their computers with the backed up data. Shouldn’t they?

Comments are closed.

Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy